Published in Tidsskr Nor Laegeforen on March 10, 1998
Seropositive arthritis in chronic lymphocytic leukemia: a remark on B cell-mediated autoimmunity. Rheumatol Int (2005) 0.76
IL-6: an early marker for outcome in acute ischemic stroke. Acta Neurol Scand (2005) 2.01
Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease. Br J Haematol (2001) 1.49
[A management program for primary thrombocytopenia]. Tidsskr Nor Laegeforen (1999) 1.38
Immunology of multiple sclerosis. Clin Neurosci (1994) 1.19
Biology of adult human microglia in culture: comparisons with peripheral blood monocytes and astrocytes. J Neuropathol Exp Neurol (1992) 1.19
Review: genetic models of acute myeloid leukaemia. Oncogene (2008) 1.14
Synergistic induction of p53 mediated apoptosis by valproic acid and nutlin-3 in acute myeloid leukemia. Leukemia (2011) 1.11
Concentrations of cytokines in plasma of patients with large burns: their relation to time after injury, burn size, inflammatory variables, infection, and outcome. Eur J Surg (1998) 1.06
B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ. Eur J Immunol (1994) 1.03
Heat shock protein 90 - a potential target in the treatment of human acute myelogenous leukemia. Curr Cancer Drug Targets (2009) 1.02
IL-10 production by adult human derived microglial cells. Neurochem Int (1996) 1.02
Expression and function of CD59 on colonic adenocarcinoma cells. Eur J Immunol (1994) 1.00
Animal models of acute myelogenous leukaemia - development, application and future perspectives. Leukemia (2005) 0.99
The expression of CD59 in normal human nervous tissue. Immunology (1994) 0.95
Soluble CD59 in pregnancy and infancy. Immunol Lett (1993) 0.93
Immunoglobulin levels amongst persons with and without human immunodeficiency virus type 1 infection in Uganda and Norway. Scand J Immunol (2004) 0.92
Fc receptor for IgG (FcR) on rat microglia. J Neuroimmunol (1994) 0.91
Cells encapsulated in alginate: a potential system for delivery of recombinant proteins to malignant brain tumours. Int J Dev Neurosci (1999) 0.90
Activation of adult human derived microglia by myelin phagocytosis in vitro. J Neurosci Res (1994) 0.89
Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosis. Cell Death Dis (2013) 0.89
Fc gamma receptor heterogeneity in the human placenta. Scand J Immunol (1990) 0.89
Specific cellular signal-transduction responses to in vivo combination therapy with ATRA, valproic acid and theophylline in acute myeloid leukemia. Blood Cancer J (2011) 0.87
Insulin-like growth factor-1 (IGF-1) has a costimulatory effect on proliferation of committed progenitors derived from human umbilical cord CD34+ cells. Stem Cells (1998) 0.85
Effects of human calprotectin (L1) on in vitro immunoglobulin synthesis. Scand J Immunol (1994) 0.84
Antigen presentation by human fetal astrocytes with the cooperative effect of microglia or the microglial-derived cytokine IL-1. J Neurosci (1995) 0.84
Characterization of ribosomal P autoantibodies in relation to cell destruction and autoimmune disease. Scand J Immunol (2004) 0.84
Large-volume leukapheresis yields more viable CD34+ cells and colony-forming units than normal-volume leukapheresis, especially in patients who mobilize low numbers of CD34+ cells. Transfusion (2005) 0.84
IgG Fc receptor heterogeneity in human peripheral nerves. Acta Neurol Scand (1991) 0.83
Identification of four SB antigens by cloned cells. Population studies of Norwegians. Tissue Antigens (1983) 0.83
The influence of tumour necrosis factor-alpha, interleukin-1 beta and interferon-gamma on the expression and function of the complement regulatory protein CD59 on the human colonic adenocarcinoma cell line HT29. Scand J Immunol (1995) 0.83
Induction of primary T cell responses by human glial cells. J Neurosci Res (1993) 0.83
T-lymphocyte functions in acute leukaemia patients with severe chemotherapy-induced cytopenia: characterization of clonogenic T-cell proliferation. Scand J Immunol (1998) 0.82
HLA-DR3 and -DR4 control T-lymphocyte responses to mumps and Coxsackie B4 virus: studies on patients with type 1 (insulin-dependent) diabetes and healthy subjects. Diabetologia (1985) 0.82
No differences in colony formation of peripheral blood stem cells frozen with 5% or 10% dimethyl sulfoxide. J Hematother Stem Cell Res (2003) 0.82
Reliability and sensitivity of diagnostic tests for primary Sjögren's syndrome. J Rheumatol (1999) 0.81
Fc gamma-receptor activity of placental annexin II. Scand J Immunol (1994) 0.81
Ribosomal proteins sustain morphology, function and phenotype in acute myeloid leukemia blasts. Leuk Res (1998) 0.81
Mycobacterium tuberculosis Mce1 protein complex initiates rapid induction of transcription of genes involved in substrate trafficking. Genes Immun (2012) 0.81
In vitro effects of insulin-like growth factor-1 (IGF-1) on proliferation and constitutive cytokine secretion by acute myelogenous leukemia blasts. Eur J Haematol (1999) 0.81
Chronic cold agglutinin disease of the "idiopathic" type is a premalignant or low-grade malignant lymphoproliferative disease. APMIS (1997) 0.81
Receptors for gammaglobulin in the central and peripheral nervous system. J Neurol Neurosurg Psychiatry (1994) 0.80
Purification of a functional 40 kD human placental Fc gamma-receptor using a monoclonal antibody. APMIS (1989) 0.80
T lymphocyte responses to Coxsackie B4 and mumps virus. I. Influence of HLA-DR restriction elements. Tissue Antigens (1985) 0.80
Immune regulatory and effector properties of human adult microglia studies in vitro and in situ. Adv Neuroimmunol (1994) 0.79
The role of the CD8-positive subset of T cells in proliferative responses to soluble antigens. I. Studies of healthy subjects, type 1 diabetics, and coeliac disease patients. Scand J Immunol (1986) 0.79
Effects of gamma-irradiation on acute myelogenous leukemia blasts: in vitro studies of proliferation, constitutive cytokine secretion, and accessory cell function during T cell activation. J Hematother Stem Cell Res (1999) 0.79
Interleukin 2- and interferon-production and expression of interleukin 2 receptors by human mononuclear cells stimulated with mumps virus or phytohaemagglutinin. Acta Pathol Microbiol Immunol Scand C (1986) 0.79
Bannwarth's syndrome: serum and CSF IgG antibodies against Borrelia burgdorferi examined by ELISA. Acta Neurol Scand (1987) 0.79
IgG allotypes and subclasses in Norwegian patients with multiple sclerosis. J Neurol Sci (2000) 0.79
Relative roles of natural killer- and T cell-mediated anti-leukemia effects in chronic myelogenous leukemia patients treated with interferon-alpha. Leuk Lymphoma (1995) 0.79
Acute myelogenous leukemia blasts as accessory cells during in vitro T lymphocyte activation. Cell Immunol (2000) 0.78
The evolution and breakdown of the immune system: implications for development of autoimmune diseases. Scand J Immunol (2002) 0.78
No response to cladribine in five patients with chronic cold agglutinin disease. Eur J Haematol (2000) 0.78
Cytokine responsiveness of mitogen-activated T cells derived from acute leukemia patients with chemotherapy-induced leukopenia. J Interferon Cytokine Res (2000) 0.78
Platelet-derived growth factor (PDGF) in human acute myelogenous leukemia: PDGF receptor expression, endogenous PDGF release and responsiveness to exogenous PDGF isoforms by in vitro cultured acute myelogenous leukemia blasts. Eur J Haematol (2001) 0.78
Circadian variations do not have a major impact on serum levels of soluble (S) L-selectin (CD63L), S-intercellular adhesion molecule 1 (sICAM-1/CD54) and thrombopoietin in healthy individuals. Scand J Clin Lab Invest (2002) 0.78
High dose methylprednisolone induces FcgammaRI on granulocytes in MS-patients. J Neuroimmunol (2005) 0.77
T lymphocyte responses to Coxsackie B4 and mumps virus. II. Immunoregulation by HLA-DR3 and -DR4 associated restriction elements. Tissue Antigens (1985) 0.77
HLA control of the proliferative T lymphocyte response to antigenic determinants on mumps virus. Studies of healthy individuals and patients with type 1 diabetes. Scand J Immunol (1985) 0.77
lacZ-neoR transfected glioma cells in syngeneic rats: growth pattern and characterization of the host immune response against cells transplanted inside and outside the CNS. Int J Cancer (2000) 0.77
Genomic HLA-DQ beta polymorphism associated with insulin-dependent diabetes mellitus. Analysis of possible functional significance. Scand J Immunol (1987) 0.76
Platelet-derived growth factor (PDGF) in human acute myelogenous leukemia: PDGF receptor expression, endogenous PDGF release and responsiveness to exogenous PDGF isoforms by in vitro cultured acute myelogenous leukemia blasts. Eur J Haematol (2001) 0.76
Measurement of IgM rheumatoid factor by ELISA. Scand J Rheumatol (2001) 0.76
The proliferative T-lymphocyte response to streptokinase. J Clin Lab Immunol (1986) 0.76
Effects of acute myelogenous leukemia blasts on platelet release of soluble P-selectin and platelet-derived growth factor. Platelets (1998) 0.76
Tumor-specific antigens revisited: presentation to the immune system of fusion peptides resulting solely from tumor-specific chromosomal translocations. Oncol Res (1992) 0.76
Inhibition of phytohaemagglutinin-induced lymphoproliferation by soluble annexin II in sera from patients with renal cell carcinoma. APMIS (1997) 0.76
High dose ara-C combined with autologous peripheral blood stem cell transplantation in the treatment of acute myelogenous leukemia: the question is still not answered. Stem Cells (2000) 0.75
Can dipyridamole or verapamil slow regrowth of leukaemia cells? Leuk Res (1992) 0.75
A dot-immunobinding assay for the demonstration of soluble Fc gamma receptors. J Immunol Methods (1994) 0.75
Suppressive effect on lymphoproliferation in vitro by soluble annexin II released from isolated placental membranes. Am J Reprod Immunol (1997) 0.75
Serum thrombopoietin levels in acute leukemia patients with chemotherapy-induced cytopenia--inverse correlation between serum levels and platelet counts. Leukemia (1998) 0.75
Increased levels of circulating interleukin-8 in patients with large burns: relation to burn size and sepsis. J Trauma (1995) 0.75
Expression and release of adhesion molecules by human acute myelogenous leukemia blasts. Leuk Res (1999) 0.75
Presence of an immunosuppressive factor in human pregnancy serum. Am J Reprod Immunol (1997) 0.75
Serum levels of soluble ICAM-1 in acute leukemia patients with chemotherapy-induced neutropenia. Leukemia (1997) 0.75
Functional differentiation of acute myeloid leukaemia blast cells. APMIS (1999) 0.75
[Immunology and malnutrition. Medical and social problems in developing countries]. Tidsskr Nor Laegeforen (1986) 0.75
Sudden death caused by heart block in a patient with multiple myeloma and cardiac amyloidosis. Acta Med Scand (1988) 0.75
Reduction of coronary artery bypass graft occlusion by dipyridamol--is immunosuppression important? Clin Immunol Immunopathol (1988) 0.75
The role of the CD8-positive subset of T cells in proliferative responses to soluble antigens. II. CD8-positive cells are not responsible for DR-associated differences in responsiveness to mumps and Coxsackie B4. Scand J Immunol (1986) 0.75
Myasthenia gravis muscle antibodies examined by ELISA: IgG and IgM antibodies characterize different patient subgroups. Acta Neurol Scand (1992) 0.75
Cytotoxic and proliferative functions of T lymphocyte clones derived very shortly after allogeneic bone marrow transplantation. Bone Marrow Transplant (1991) 0.75
[Cyclosporin A. Inhibitory effect on T lymphocytes]. Tidsskr Nor Laegeforen (1986) 0.75
Effect of verapamil on T-lymphocyte activation in vitro. Scand J Immunol (1985) 0.75
[High-dose therapy with autologous stem cell support in malignant diseases]. Tidsskr Nor Laegeforen (1994) 0.75
Production of interleukin 2 containing growth medium for cloning of human T lymphocytes. J Immunol Methods (1984) 0.75
[Experiences from a stroke unit in a county hospital]. Tidsskr Nor Laegeforen (1993) 0.75
[Treatment with high-dose cytostatic agents]. Tidsskr Nor Laegeforen (1994) 0.75
The effect of disodium cromoglycate on in vitro proliferation of peripheral blood mononuclear cells from allergic and healthy donors. Scand J Immunol (1992) 0.75
The effect of theophyllamine on T-lymphocyte activation in vitro. Clin Immunol Immunopathol (1984) 0.75
[The genetic background of type I (insulin-dependent) diabetes mellitus]. Tidsskr Nor Laegeforen (1986) 0.75
Dipyridamol inhibits activation of human T lymphocytes in vitro. Clin Immunol Immunopathol (1987) 0.75
Studies on the HLA association to insulin-dependent diabetes mellitus (IDDM). Pol Arch Med Wewn (1990) 0.75
[The cellular immune system. Possible adverse effects of drugs]. Tidsskr Nor Laegeforen (1986) 0.75
[The medical leech--Hirudo medicinalis. Natural occurrence, medical use and complications]. Tidsskr Nor Laegeforen (1987) 0.75
[Fever of unknown origin in adults with malignant diseases]. Tidsskr Nor Laegeforen (1983) 0.75